Foghorn Therapeutics Inc.
HealthcareNASDAQ:FHTX · NASDAQ Global Market
+$0.12 today
Vol 0.16M · Avg 0.16M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-3.24%
Period High
$6.68
Period Low
$3.53
Latest
$4.18
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$364.90M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$353.00M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$276.28M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
Zura Bio Limited
NASDAQ:ZURA
$240.58M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$211.13M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$198.11M
Humacyte, Inc.
NASDAQ:HUMA
$177.24M
Immuneering Corporation
NASDAQ:IMRX
$152.11M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$111.51M
What is the latest FHTX filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does FHTX have?
Intrinsic Alpha currently shows 20 recent filings for FHTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.